Targeting PSMD14 inhibits melanoma growth through SMAD3 stabilization

Although melanoma therapy is improved by novel molecular targeted reagents, including vemurafenib, aberrant proliferation and early metastasis remain obstacles for melanoma; therefore, novel target molecules for melanoma need to be identified. In this study, we focused on deubiquitinating enzymes, w...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Sci Rep
Главные авторы: Yokoyama, Satoru, Iwakami, Yusuke, Hang, Zhao, Kin, Ryoei, Zhou, Yue, Yasuta, Yutaka, Takahashi, Atsushi, Hayakawa, Yoshihiro, Sakurai, Hiroaki
Формат: Artigo
Язык:Inglês
Опубликовано: Nature Publishing Group UK 2020
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7644625/
https://ncbi.nlm.nih.gov/pubmed/33154524
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-020-76373-y
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы